Below are the top drugs-generic stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc HITK is 33.13%. HITK's revenue for the same period is $219.97 million.
The trailing-twelve-month operating margin at Salix Pharmaceuticals Ltd SLXP is 25.63%. SLXP's ROE for the same period is 18.41%.
The trailing-twelve-month operating margin at Akorn Inc AKRX is 21.78%. AKRX's PEG ratio is 0.80.
The trailing-twelve-month operating margin at Mylan Inc MYL is 16.95%. MYL's revenue for the same period is $6.03 billion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in